Physician profile
Doreen Chen
NPI 1760802011
$805.95
in general payments reported to CMS, 2019-2025
9 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $151 · 2023: $189 · 2024: $187 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $252.00 | 2020-2023 | Tezspire |
| Gilead Sciences, INC. | $151.23 | 2025 | Vemlidy |
| Eisai INC. | $124.98 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $100.00 | 2025 | Neffy |
| Janssen Pharmaceuticals, INC | $53.79 | 2023-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $41.62 | 2023-2024 | Dificid, Zerbaxa |
| Abbvie INC. | $30.96 | 2023-2024 | Avycaz |
| Astellas Pharma US INC | $27.29 | 2025 | Veozah |
| Allergan, INC. | $24.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doreen Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.